Longitudinal multimodal study in Persian cohort found OCT retinal biomarkers may indicate structural decline in Parkinson’s Disease.
Retinal alterations in PD are closely aligned with concurrent brain neurodegeneration and may serve as predictive biomarkers. These findings suggest that OCT, when combined with MRI, may support a non-invasive strategy for early risk stratification and longitudinal monitoring of PD.
No takes yet. Share an insight, caveat, or question.
Nikparast et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: